Tue, Aug 20 10:30am

Ionis Pharmaceuticals Inc [IONS]
$70.72 0.72 (1.03%)

IONS Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 9.71 Billion
IONS Description

Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Ionis' broad clinical and preclinical pipeline treats a wide variety of diseases, with an emphasis on cardiovascular, metabolic, severe, and rare diseases. Ionis sold rights to its first product, Kynamro, to Kastle Therapeutics after lackluster commercial success, but with partner Biogen brought its second drug, Spinraza for spinal muscular atrophy, to market. ATTR amyloidosis drug Tegsedi (inotersen) was approved in 2018 and cardiology drug Waylivra was approved in Europe in 2019.

Visit Website

IONS Earnings

EPS -0.01 P/E Ratio 41.01
Previous Earnings Thu, May 9, 2019
Latest Earnings Wed, Aug 7, 2019 (13 days ago) +9.26%

IONS Dividend

Yield --
Ex-Date --
Pay Date --
History --

IONS Charts

1 Year
Oct 11, 2018
Apr 8, 2019

Symbol Price Day % YTD %
IONS $70.72 1.03% 31.52%

Symbol Surfing

How can we make Symbol Surfing better?


Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy